Compensation 990
OrganizationsEmployeesBoard MembersGrantsContractorsTop RankingsPricing

Stay updated on 990 organization compensation

© Civic Register LLC

Compensation 990 is an independent service that uses public IRS Form 990 filings as its source data. We clean and standardize this information, but the original filings may contain errors or omissions. Years on this site refer to the organization’s fiscal year end date on the filing.

About•Report a discrepancy•Your privacy choices
Organizations Mental Health & Crisis Intervention Speakup About Drugs

Speakup About Drugs

Fiscal year ending 2024. Filed on November 17, 2025.

313 NW Lasalle Dr
Bentonville, Arkansas 72712

Speakup About Drugs (EIN: 82-3425247) has filed an IRS Form 990 since fiscal year 2021. In its fiscal year 2024 IRS Form 990 filing, Speakup About Drugs, a 501(c)(3) charitable organization, reported compensation for 0 out of 2 total employees.

Revenue, expenses, and employee compensation

Revenue

$105,249

Expenses

$142,097

Employee compensation

$69,702
Revenue, expenses, and employee compensation over time

Reported Compensated Employees

No compensated employees were reported for this year (employee data available for 2023, 2022, 2021).

Non-Employee Board Members

Gina Allgaier
Executive Director
$44,804
$44,804 No related compNo other comp
Andrew Agar
Director
No compensation reported
Katy Restum
Director
No compensation reported
Teresa Belew
Director
No compensation reported
Pat Allgaier
Treasurer
No compensation reported

Mission Statement

TO EDUCATE SUPPORT AND ADVOCATE FOR INDIVIDUALS AND FAMILIES WHO ARE VICTIMS OF THE DRUG EPIDEMIC

Revisions to this organization profile

November 17, 2025:
2024 Speakup About Drugs 990 filed
November 16, 2024:
2023 Speakup About Drugs 990 filed
October 11, 2023:
2022 Speakup About Drugs 990 filed

Get an email when new compensation information is released for Speakup About Drugs

Be the first to know when new IRS Form 990 data is published for this organization.

Related Jobs

View more jobs
Powered by Talroo
Report a discrepancy →